LISATA THERAPEUTICS, INC. Investment Income, Net
LISATA THERAPEUTICS, INC. (LSTA) reported Investment Income, Net of $79.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. investment income, net for the quarter ending 2026-06-30 was $79.00K, a 63.43% decline year-over-year.
- LISATA THERAPEUTICS, INC. investment income, net for the quarter ending 2026-03-31 was $120.00K, a 54.89% decline year-over-year.
- LISATA THERAPEUTICS, INC. investment income, net for the quarter ending 2025-12-31 was $141.00K, a 59.71% decline year-over-year.
- LISATA THERAPEUTICS, INC. investment income, net for the quarter ending 2025-09-30 was $183.00K, a 59.42% decline year-over-year.
- LISATA THERAPEUTICS, INC. investment income, net for fiscal 2025 was $806.00K, a 57.20% decline from fiscal 2024.
- LISATA THERAPEUTICS, INC. investment income, net for fiscal 2024 was $1.88M, a 30.87% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. investment income, net for fiscal 2023 was $2.72M, a 158.94% increase from fiscal 2022.
- LISATA THERAPEUTICS, INC. investment income, net for fiscal 2022 was $1.05M, a 596.69% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $79.00K 10-Q · filed 2026-08-06 | $199.00K 10-Q · filed 2026-08-06 | $340.00K derived: sum of 3 quarters · filed 2026-08-06 | $523.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $120.00K 10-Q · filed 2026-05-11 | $261.00K derived: sum of 2 quarters · filed 2026-05-11 | $444.00K derived: sum of 3 quarters · filed 2026-05-11 | $660.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $324.00K derived: sum of 2 quarters · filed 2026-03-12 | $540.00K derived: sum of 3 quarters · filed 2026-08-06 | $806.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $183.00K 10-Q · filed 2025-11-06 | $399.00K derived: sum of 2 quarters · filed 2026-08-06 | $665.00K 10-Q · filed 2025-11-06 | $1.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $216.00K 10-Q · filed 2026-08-06 | $482.00K 10-Q · filed 2026-08-06 | $832.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $266.00K 10-Q · filed 2026-05-11 | $616.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.07M derived: sum of 3 quarters · filed 2026-05-11 | $1.56M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $801.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.29M derived: sum of 3 quarters · filed 2026-03-12 | $1.88M 10-K · filed 2026-03-12 |
| 2024-09-30 | $451.00K 10-Q · filed 2025-11-06 | $944.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.53M 10-Q · filed 2025-11-06 | $2.20M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $493.00K 10-Q · filed 2025-08-07 | $1.08M 10-Q · filed 2025-08-07 | $1.75M derived: sum of 3 quarters · filed 2025-08-07 | $2.47M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $589.00K 10-Q · filed 2025-05-08 | $1.26M derived: sum of 2 quarters · filed 2025-05-08 | $1.97M derived: sum of 3 quarters · filed 2025-05-08 | $2.64M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.39M derived: sum of 2 quarters · filed 2025-02-27 | $2.05M derived: sum of 3 quarters · filed 2025-02-27 | $2.72M 10-K · filed 2025-02-27 |
| 2023-09-30 | $714.00K 10-Q · filed 2024-11-12 | $1.38M derived: sum of 2 quarters · filed 2024-11-12 | $2.05M 10-Q · filed 2024-11-12 | $2.61M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $668.00K 10-Q · filed 2024-08-12 | $1.34M 10-Q · filed 2024-08-12 | $1.89M derived: sum of 3 quarters · filed 2024-08-12 | $2.23M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $670.00K 10-Q · filed 2024-05-09 | $1.23M derived: sum of 2 quarters · filed 2024-05-09 | $1.56M derived: sum of 3 quarters · filed 2024-05-09 | $1.66M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $893.00K derived: sum of 2 quarters · filed 2024-02-29 | $987.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.05M 10-K · filed 2024-02-29 |
| 2022-09-30 | $337.00K 10-Q · filed 2023-11-02 | $431.00K derived: sum of 2 quarters · filed 2023-11-02 | $496.00K 10-Q · filed 2023-11-02 | $534.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $94.00K 10-Q · filed 2023-08-14 | $158.00K 10-Q · filed 2023-08-14 | $197.00K derived: sum of 3 quarters · filed 2023-08-14 | $238.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $63.00K 10-Q · filed 2023-05-09 | $103.00K derived: sum of 2 quarters · filed 2023-05-09 | $144.00K derived: sum of 3 quarters · filed 2023-05-09 | $191.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $81.00K derived: sum of 2 quarters · filed 2023-03-30 | $128.00K derived: sum of 3 quarters · filed 2023-03-30 | $151.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $41.00K 10-Q · filed 2022-11-10 | $88.00K derived: sum of 2 quarters · filed 2022-11-10 | $111.00K 10-Q · filed 2022-11-10 | $125.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $47.00K 10-Q · filed 2022-08-04 | $70.00K 10-Q · filed 2022-08-04 | $84.00K derived: sum of 3 quarters · filed 2022-08-04 | $109.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $23.00K 10-Q · filed 2022-05-05 | $37.00K derived: sum of 2 quarters · filed 2022-05-05 | $62.00K derived: sum of 3 quarters · filed 2022-05-05 | $84.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $39.00K derived: sum of 2 quarters · filed 2022-03-22 | $61.00K derived: sum of 3 quarters · filed 2022-03-22 | $132.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $25.00K 10-Q · filed 2021-11-04 | $47.00K derived: sum of 2 quarters · filed 2021-11-04 | $118.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $22.00K 10-Q · filed 2021-08-05 | $93.00K 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |